WaferGen, Qiagen Ink Co-Marketing Agreement in Japan | GenomeWeb

NEW YORK (GenomeWeb News) — WaferGen Biosystems and Qiagen KK, the Japanese subsidiary of Qiagen, said today that they have inked a co-marketing agreement for genomics products.

Under the agreement, Qiagen and WaferGen will promote each other's products in Japan. In particular, the companies will co-market WaferGen's SmartChip Real-Time PCR system and Qiagen's PCR arrays and next-generation sequencing platform, the latter of which is currently in an "advanced stage of development," the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.